ConductScience.org, home

Trial · NCT01146652

Adverse events998

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherLeukopeniaBlood and lymphatic system disordersSarilumab + Disease Modifying Anti-Rheumatic Drugs (DMARD)1011,910181
otherLeukopeniaBlood and lymphatic system disordersSarilumab Monotherapy41115
otherNeutropeniaBlood and lymphatic system disordersSarilumab + Disease Modifying Anti-Rheumatic Drugs (DMARD)3481,910786
otherNeutropeniaBlood and lymphatic system disordersSarilumab Monotherapy1811164
otherDiarrhoeaGastrointestinal disordersSarilumab + Disease Modifying Anti-Rheumatic Drugs (DMARD)1221,910153
otherDiarrhoeaGastrointestinal disordersSarilumab Monotherapy21112
otherInjection Site ErythemaGeneral disordersSarilumab + Disease Modifying Anti-Rheumatic Drugs (DMARD)1111,910751
otherInjection Site ErythemaGeneral disordersSarilumab Monotherapy01110
otherBronchitisInfections and infestationsSarilumab + Disease Modifying Anti-Rheumatic Drugs (DMARD)2151,910301
otherBronchitisInfections and infestationsSarilumab Monotherapy1211119
otherInfluenzaInfections and infestationsSarilumab + Disease Modifying Anti-Rheumatic Drugs (DMARD)1241,910160
otherInfluenzaInfections and infestationsSarilumab Monotherapy31114
otherNasopharyngitisInfections and infestationsSarilumab + Disease Modifying Anti-Rheumatic Drugs (DMARD)2491,910390
otherNasopharyngitisInfections and infestationsSarilumab Monotherapy1411126
otherPharyngitisInfections and infestationsSarilumab + Disease Modifying Anti-Rheumatic Drugs (DMARD)1101,910129
otherPharyngitisInfections and infestationsSarilumab Monotherapy41114
otherUpper Respiratory Tract InfectionInfections and infestationsSarilumab + Disease Modifying Anti-Rheumatic Drugs (DMARD)3031,910574
otherUpper Respiratory Tract InfectionInfections and infestationsSarilumab Monotherapy1611121
otherUrinary Tract InfectionInfections and infestationsSarilumab + Disease Modifying Anti-Rheumatic Drugs (DMARD)2641,910428
otherUrinary Tract InfectionInfections and infestationsSarilumab Monotherapy1411122

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01146652/events